Basics Organon & Co.. IPO Date: May 14, 2021 Sector: Healthcare Industry: Drug Manufacturers - General Market Cap: $2.4B Activated in VL: True Average Daily Range Avg Daily Range: $0.37 | 1.62% Avg Daily Range (30 D): $0.31 | 3.29% Avg Daily Range (90 D): $0.33 | 2.73% Institutional Daily Volume Avg Daily Volume: 2.28M Avg Daily Volume (30 D): 6.48M Avg Daily Volume (90 D): 4.22M Trade Size Avg Trade Size (Sh.): 97 Avg Trade Size (Sh.) (30 D): 155 Avg Trade Size (Sh.) (90 D): 121 Institutional Trades Total Inst.Trades: 3,761 Avg Inst. Trade: $3.48M Avg Inst. Trade (30 D): $3.19M Avg Inst. Trade (90 D): $3.61M Avg Inst. Trade Volume: .16M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $8.21M Avg Closing Trade (30 D): $7.64M Avg Closing Trade (90 D): $8.33M Avg Closing Volume: 380.94K     News Jun 8, 2025 @ 12:19 PM ROSEN, SKILLED INVESTOR COUNSEL, Encourages Organo... Source: N/A Jun 8, 2025 @ 12:18 PM OGN INVESTOR NEWS: Organon & Co. has been Sued for... Source: N/A Jun 5, 2025 @ 2:31 AM ORGANON SHAREHOLDER ALERT: CLAIMSFILER REMINDS INV... Source: Claimsfiler Jun 4, 2025 @ 2:32 AM ORGANON SHAREHOLDER ALERT BY FORMER LOUISIANA ATTO... Source: Kahn Swick & Foti, Llc Jun 3, 2025 @ 9:11 PM OGN Stock Alert: Organon & Co. Shareholders with L... Source: Robbins Llp Financials   TTM Q1 2025 Q4 2024 Basic EPS $2.91 $.34 $.42 Diluted EPS $2.87 $.33 $.41 Revenue $ 6.29B $ 1.51B $ 1.59B Gross Profit $ 3.6B $ 841M $ 896M Net Income / Loss $ 750M $ 87M $ 109M Operating Income / Loss $ 672M $ 101M $ 129M Cost of Revenue $ 2.7B $ 672M $ 696M Net Cash Flow $ -28M $ -128M $ -88M PE Ratio 3.32